OX40 gene expression is up-regulated by chromatin remodeling in its promoter region containing Sp1/Sp3, YY1, and NF-κB binding sites

Journal of Immunology

Volumn 179, Issue 3, 2007, Pages 1760-1767

  Tone, Yukiko ^a   Kojima, Yoshitsugu ^a   Furuuchi, Keiji ^a   Brady, Maya ^a   Yashiro Ohtani, Yumi ^a   Tykocinski, Mark L ^a   Tone, Masahide ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY; HISTONE H4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN OX40; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TRANSCRIPTION FACTOR YY1; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; ANTISERUM; CD134 ANTIGEN; CD3 ANTIGEN; MESSENGER RNA; NFKB1 PROTEIN, MOUSE; TNFRSF4 PROTEIN, MOUSE; YY1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BINDING SITE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; UPREGULATION; ANIMAL; BIOSYNTHESIS; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; T CELL LYMPHOMA; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD3; BINDING SITES; CELL LINE, TUMOR; CHROMATIN ASSEMBLY AND DISASSEMBLY; IMMUNE SERA; LYMPHOCYTE ACTIVATION; LYMPHOMA, T-CELL; MICE; NF-KAPPA B P50 SUBUNIT; PROMOTER REGIONS (GENETICS); RECEPTORS, OX40; RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TRANSCRIPTION FACTOR RELA; UP-REGULATION; YY1 TRANSCRIPTION FACTOR;

EID: 34548649774     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.3.1760     Document Type: Article

References (44)

1. Watts, T. H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23: 23-68.
2. Paterson, D. J., W. A. Jefferies, J. R. Green, M. R. Brandon, P. Corthesy, M. Puklavec, and A. F. Williams. 1987. Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol. Immunol. 24: 1281-1290.
3. Gramaglia, I., A. D. Weinberg, M. Lemon, and M. Croft. 1998. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J. Immunol. 161: 6510-6517.
4. Sugamura, K., N. Ishii, and A. D. Weinberg. 2004. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat. Rev. Immunol. 4: 420-431.
5. Gramaglia, I., A. Jember, S. D. Pippig, A. D. Weinberg, N. Killeen, and M. Croft. 2000. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J. Immunol. 165: 3043-3050.
6. Maxwell, J. R., A. Weinberg, R. A. Prell, and A. T. Vella. 2000. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion. J. Immunol. 164: 107-112.
7. So, T., J. Song, K. Sugie, A. Altman, and M. Croft. 2006. Signals from OX40 regulate nuclear factor of activated T cells c1 and T cell helper 2 lineage commitment. Proc. Natl. Acad. Sci. USA 103: 3740-3745.
8. Kopf, M., C. Ruedl, N. Schmitz, A. Gallimore, K. Lefrang, B. Ecabert, B. Odermatt, and M. F. Bachmann. 1999. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection. Immunity 11: 699-708.
9. Chen, A. I., A. J. McAdam, J. E. Buhlmann, S. Scott, M. L. Lupher, Jr., E. A. Greenfield, P. R. Baum, W. C. Fanslow, D. M. Calderhead, G. J. Freeman, and A. H. Sharpe. 1999. Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. Immunity 11: 689-698.
10. Brocker, T., A. Gulbranson-Judge, S. Flynn, M. Riedinger, C. Raykundalia, and P. Lane. 1999. CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles. Eur. J. Immunol. 29: 1610-1616.
11. Roos, A., E. J. Schilder-Tol, J. J. Weening, and J. Aten. 1998. Strong expression of CD134 (OX40), a member of the TNF receptor family, in a T helper 2-type cytokine environment. J. Leukocyte Biol. 64: 503-510.
12. L and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity 15: 445-455.
13. Song, J., S. Salek-Ardakani, P. R. Rogers, M. Cheng, L. Van Parijs, and M. Croft. 2004. The costimulation-regulated duration of PKB activation controls T cell longevity. Nat. Immunol. 5: 150-158.
14. Kawamata, S., T. Hori, A. Imura, A. Takaori-Kondo, and T. Uchiyama. 1998. Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-κB activation. J. Biol. Chem. 273: 5808-5814.
15. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16: 311-323.
16. Takeda, I., S. Ine, N. Killeen, L. C. Ndhlovu, K. Murata, S. Satomi, K. Sugamura, and N. Ishii. 2004. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells. J. Immunol. 172: 3580-3589.
17. + T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. Blood 105: 2845-2851.
18. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3: 135-142.
19. Tone, M., Y. Tone, E. Adams, S. F. Yates, M. R. Frewin, S. P. Cobbold, and H. Waldmann. 2003. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc. Natl. Acad. Sci. USA 100: 15059-15064.
20. Tone, M., M. J. Powell, Y. Tone, S. A. Thompson, and H. Waldmann. 2000. IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3. J. Immunol. 165: 286-291.
21. Frohman, M. A., M. K. Dush, and G. R. Martin. 1988. Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci. USA 85: 8998-9002.
22. Tone, M., Y. Tone, J. M. Babik, C. Y. Lin, and H. Waldmann. 2002. The role of Sp1 and NF-κB in regulating CD40 gene expression. J. Biol. Chem. 277: 8890-8897.
23. Barreau, C., L. Paillard, and H. B. Osborne. 2005. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res. 33: 7138-7150.
24. Chen, C. Y., and A. B. Shyu. 1995. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20: 465-470.
25. Powell, M. J., S. A. Thompson, Y. Tone, H. Waldmann, and M. Tone. 2000. Posttranscriptional regulation of IL-10 gene expression through sequences in the 3′-untranslated region. J. Immunol. 165: 292-296.
26. Hagen, G., S. Muller, M. Beato, and G. Suske. 1994. Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J. 13: 3843-3851.
27. Badran, B. M., S. M. Wolinsky, A. Burny, and K. E. Willard-Gallo. 2002. Identification of three NFAT binding motifs in the 5′-upstream region of the human CD3γ gene that differentially bind NFATc1, NFATc2, and NF-κB p50. J. Biol. Chem. 277: 47136-47148.
28. de Lumley, M., D. J. Hart, M. A. Cooper, S. Symeonides, and J. M. Blackburn. 2004. A biophysical characterisation of factors controlling dimerisation and selectivity in the NF-κB and NFAT families. J. Mol. Biol. 339: 1059-1075.
29. Giffin, M. J., J. C. Stroud, D. L. Bates, K. D. von Koenig, J. Hardin, and L. Chen. 2003. Structure of NFAT1 bound as a dimer to the HIV-1 LTR κB element. Nat. Struct. Biol. 10: 800-806.
30. Jin, L., P. Sliz, L. Chen, F. Macian, A. Rao, P. G. Hogan, and S. C. Harrison. 2003. An asymmetric NFAT1 dimer on a pseudo-palindromic κB-like DNA site. Nat. Struct. Biol. 10: 807-811.
31. Wolfe, S. A., P. Zhou, V. Dotsch, L. Chen, A. You, S. N. Ho, G. R. Crabtree, G. Wagner, and G. L. Verdine. 1997. Unusual Rel-like architecture in the DNA-binding domain of the transcription factor NFATc. Nature 385: 172-176.
32. Sheppard, K. A., D. W. Rose, Z. K. Haque, R. Kurokawa, E. McInerney, S. Westin, D. Thanos, M. G. Rosenfeld, C. K. Glass, and T. Collins. 1999. Transcriptional activation by NF-κB requires multiple coactivators. Mol. Cell Biol. 19: 6367-6378.
33. Zhong, H., R. E. Voll, and S. Ghosh. 1998. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1: 661-671.
34. Zhong, H., M. J. May, E. Jimi, and S. Ghosh. 2002. The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1. Mol. Cell 9: 625-636.
35. Walker, L. S., A. Gulbranson-Judge, S. Flynn, T. Brocker, C. Raykundalia, M. Goodall, R. Forster, M. Lipp, and P. Lane. 1999. Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers. J. Exp. Med. 190: 1115-1122.
36. Toennies, H. M., J. M. Green, and R. H. Arch. 2004. Expression of CD30 and Ox40 on T lymphocyte subsets is controlled by distinct regulatory mechanisms. J. Leukocyte Biol. 75: 350-357.
37. Hilton, T. L., Y. Li, E. L. Dunphy, and E. H. Wang. 2005. TAF1 histone acetyltransferase activity in Sp1 activation of the cyclin D1 promoter. Mol. Cell Biol. 25: 4321-4332.
38. Hung, J. J., Y. T. Wang, and W. C. Chang. 2006. Sp1 deacetylation induced by phorbol ester recruits p300 to activate 12(S)-lipoxygenase gene transcription. Mol. Cell Biol. 26: 1770-1785.
39. Lee, J. S., K. M. Galvin, R. H. See, R. Eckner, D. Livingston, E. Moran, and Y. Shi. 1995. Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes Dev. 9: 1188-1198.
40. Yang, W. M., C. Inouye, Y. Zeng, D. Bearss, and E. Seto. 1996. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc. Natl. Acad. Sci. USA 93: 12845-12850.
41. Yang, W. M., Y. L. Yao, J. M. Sun, J. R. Davie, and E. Seto. 1997. Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family. J. Biol. Chem. 272: 28001-28007.
42. Gordon, S., G. Akopyan, H. Garban, and B. Bonavida. 2006. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 25: 1125-1142.
43. Lee, J. S., K. M. Galvin, and Y. Shi. 1993. Evidence for physical interaction between the zinc-finger transcription factors YY1 and Sp1. Proc. Natl. Acad. Sci. USA 90: 6145-6149.
44. Seto, E., B. Lewis, and T. Shenk. 1993. Interaction between transcription factors Sp1 and YY1. Nature 365: 462-464.